Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.
Venter Steps Down As Celera President; Moffitt, Puerto Rico Center Win NCI P20 Grant.
Susan Sieber, Former NCI Communications Chief, Dead.
Andrew von Eschenbach Sworn In As NCI Director.
Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.
Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.
FDA Approves Abbott’s HER-2 DNA Probe Kit.
Univ. Of Pittsburgh Plans Molecular Medicine Institute.
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Anthony Letai pledges to ensure stability for extramural and intramural cancer science









